Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Aravive, Inc. (ARAV) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: " "
10/28/2021 8-K Investor presentation, Quarterly results
Docs: " ",
" "
08/05/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
11/05/2020 8-K Quarterly results
Docs: "Aravive Reports Third Quarter 2020 Financial Results and Provides Corporate Updates"
08/03/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
03/27/2020 8-K Investor presentation, Quarterly results
Docs: "Aravive Reports Fourth Quarter and Twelve Months Ended December 31, 2019 Financial Results and Provides Recent Corporate Updates &#x2022",
"Investor Presentation, dated March 2020"
11/08/2019 8-K Quarterly results
Docs: "CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates"
11/07/2019 8-K Quarterly results
Docs: "Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates"
08/07/2019 8-K Quarterly results
Docs: "Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates"
05/08/2019 8-K Quarterly results
Docs: "Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates"
11/06/2018 8-K Quarterly results
Docs: "Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates - Merger completed; now operating as Aravive, Inc. , a clinical-stage biopharmaceutical company advancing innovative oncology therapeutics"
08/08/2018 8-K/A Quarterly results
Docs: "Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments"
03/05/2018 8-K/A Quarterly results
Docs: "Q4_FY17 EARNINGS PR_AMENDED"
03/01/2018 8-K Quarterly results
Docs: "Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update MENLO PARK, Calif., Mar. 1, 2018"
10/26/2017 8-K Quarterly results
07/27/2017 8-K Quarterly results
Docs: "Q217 PR"
04/27/2017 8-K Form 8-K - Current report
02/21/2017 8-K Quarterly results
Docs: "VSAR Q416 EARNINGS PR"
11/03/2016 8-K Form 8-K - Current report
07/28/2016 8-K Form 8-K - Current report
04/28/2016 8-K Quarterly results
Docs: "Versartis Reports First Quarter 2016 Financial Results"
02/18/2016 8-K Quarterly results
Docs: "Versartis Reports Fourth Quarter and Full Year 2015 Financial Results"
10/29/2015 8-K Quarterly results
Docs: "Versartis Reports Third Quarter 2015 Financial Results"
08/04/2015 8-K Quarterly results
Docs: "Versartis Reports Second Quarter 2015 Financial Results"
05/06/2015 8-K Quarterly results
Docs: "Versartis Provides Update on Clinical Programs and Reports First Quarter 2015 Financial Results"
02/13/2015 8-K Quarterly results
Docs: "Versartis Reports Fourth Quarter and Full Year 2014 Financial Results"
11/06/2014 8-K Quarterly results
Docs: "Versartis Reports Third Quarter 2014 Financial Results Conference Call and Webcast Scheduled for 4:30 p.m. ET on November 6, 2014"
08/05/2014 8-K Quarterly results
Docs: "Versartis Reports Second Quarter 2014 Financial Results Menlo Park, Calif., August 5, 2014 — Versartis, Inc. , an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human growth hormone , today announced financial results for the second quarter ended June 30, 2014. “In June we achieved a major corporate milestone with our positive Phase 2a clinical results for VRS-317, confirming our potential to provide a differentiated, long-acting growth hormone to doctors, patients, and their care-givers and positioning us to move forward with a Phase 3 clinical trial in early 2015,” said Jeffrey L. Cleland, PhD, Chief Executive Officer. “We also made excellent progress with other key initiatives including the initiation of and enrollment in the VRS-..."
05/05/2014 8-K Quarterly results
Docs: "Versartis Reports First Quarter 2014 Financial Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy